SCHEMBL3924910

SCHEMBL3924910

CNC(=N)CCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3070171 0.79
SCHEMBL3081263 0.76 FAAH (0.34)
SCHEMBL28272873 0.75
SCHEMBL28195215 0.75
SCHEMBL1297846 0.74
Hydrochloric Acid SCHEMBL3355086 0.72 LMNA (0.48)
Succinamide SCHEMBL28157588 0.71 LMNA (0.50)
Succinamide SCHEMBL36057 0.71
SCHEMBL10425752 0.70
SCHEMBL27532320 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3173408-A1 PHENYL TETRAHYDROISOQUINOLINE COMPOUND SUBSTITUTED WITH HETEROARYL Taisho Pharmaceutical Co., Ltd. (JP) 2017-05-31 EP disclosed
EP-2035401-A2 ARYL- AND HETEROARYL-ETHYL-ACYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS Sanofi-Aventis (FR) 2009-03-18 EP disclosed
WO-2007144769-A2 ARYL- AND HETEROARYL-ETHYL-ACYLGUANIDINE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS SANOFI-AVENTIS (FR) 2007-12-21 WO disclosed